Chang-ki Kim

Gyeonggi-do, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Nationwide seroprevalence of severe fever with thrombocytopenia syndrome virus in South Korea: Regional patterns and public health implications.

Nationwide seroprevalence of severe fever with thrombocytopenia syndrome virus in South Korea: Regional patterns and public health implications.

Journal: Ticks and tick-borne diseases

Published: February 04, 2025

Seroprevalence survey and estimated infection fatality rate of SARS-CoV-2 in Daegu, Republic of Korea - Lessons learned for preparing for new emerging viral disease epidemics: A cross-sectional study.

Seroprevalence survey and estimated infection fatality rate of SARS-CoV-2 in Daegu, Republic of Korea - Lessons learned for preparing for new emerging viral disease epidemics: A cross-sectional study.

Journal: Medicine

Published: January 29, 2025

Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.

Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.

Journal: Journal of clinical microbiology

Published: January 05, 2023

Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.

Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay.

Journal: Virus research

Published: February 02, 2021

Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins.

Comparative analysis of mutational hotspots in the spike protein of SARS-CoV-2 isolates from different geographic origins.

Journal: Gene reports

Published: December 12, 2020

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

Journal: Trials

Published: March 06, 2018

Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.

Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: August 26, 2017

RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.

RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.

Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Published: July 29, 2016

Effect of drug resistance on negative conversion of sputum culture in patients with pulmonary tuberculosis.

Effect of drug resistance on negative conversion of sputum culture in patients with pulmonary tuberculosis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 12, 2015

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 29, 2015

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 25, 2014

Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Journal: World journal of microbiology & biotechnology

Published: November 01, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026